DIAFIR has been established in June 2011 by an interdisciplinary team of researchers and engineers, in order to bring to market more than 10 years of research made by Rennes 1 university.

Its mission it to promote innovative systems based upon special glasses, known as “chalcogenide glasses”.

These glasses have interesting properties for infrared light optics for instance. They can be used to make unique biosensors that allow faster and less invasive diagnostic procedures, for chronic and infectious diseases, as well as tumor detection.

DIAFIR testing offers a better care to the patient, saving him lesions and/or hospital stay generated by invasive or time consuming procedures. It helps physician to get easily a more accurate diagnosis.


Paper: The Economic and Clinical Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the United States and Europe

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease. There is uncertainty around the economic burden of NAFLD. We constructed a steady-state prevalence model to quantify this burden in the United States of America (USA) and Europe (EU).

Diafir at AFEF, Bordeaux, France. 2016, September 28 - October 1st

Pr Rodolphe ANTY, CHU de Nice, will introduce 2 new applications of SPID spectrometer during the next European congress of hepatology.

1- Oral presentation of blood-based diagnostic test for NASH in morbid obese.

2 - Poster on rapid diagnostic of Spontaneous Bacterial Peritonitis at the point of care

ISO 13485 certification

Further to its successul princepts presentation of NASH and infection diagnostics, Diafir receivedtl_files/media/logos/iso13485.jpg its 13485 ISO certification to get ready for the market.